Gene MassID, a student team competing in the fall seed Funding Pitch Competition organized by the University of Arkansas’ Office of Entrepreneurship and Innovation, has secured $2,000 for legal fees and further research.

This team is focused on improving treatment for brain cancer through DNA analysis by developing a diagnostic tool that uses personalized medicine to treat glioblastoma multiforme. This is an aggressive form of cancer with a 95% mortality rate.

The startup believes their tool will help to get rid of guesswork in brain cancer treatment, giving patients another chance at life.

Gene MassID was among 10 teams to receive funding in the Oct. 11 competition, which awarded more than $10,000. The competition was held in tandem with OEI’s inaugural SEED Arkansas Summit and hosted at the David and Barbara Pryor Center for Arkansas Oral and Visual History in downtown Fayetteville.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Texas Overhauls R&D Franchise Tax Credit and Advances Small‑Business Reforms

Houston-based Axiom Space has partnered with Prada to bring fashion and function to new heights – astronomical heights. The startup has unveiled their brand new spacesuit at the International Astronautical Congress in Milan.

Wales Patent of the Month – May 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Wales Patent of the Month – April 2025

A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.

Please call: 1-800-986-4725
or have Swanson Reed call you.

Privacy and Complaint Policy

Copyright Notice ©